Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gross

Showing results (181-190 of 244) with videos related to

Pageof 25
Sort By:
Biological Psychiatry Global Open Science|December 24, 2025
A Placebo-Controlled Randomized Trial of the Effects of Escitalopram on Depressive Symptoms and Immune Function in People With HIVDwight L Evans, Sergei Spitsin, Kevin G Lynch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2018
Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and ResearchRobert A Schnoll, Morgan Thompson, Katrina Serrano, et al.
Methods of Information in Medicine|March 28, 2018
Development and Usability of a Smartphone Application for Tracking Antiretroviral Medication Refill Data for Human Immunodeficiency VirusDagan Coppock, Dikai Zambo, Dumisani Moyo, et al.
AIDS (London, England)|April 5, 2019
Differences in the rate of nicotine metabolism among smokers with and without HIVRebecca L Ashare, Morgan Thompson, Frank Leone, et al.
Clinical Pharmacology and Therapeutics|October 3, 2023
Nicotine Metabolite Ratio Decreases After Switching Off Efavirenz-Based Therapy in People With HIV Who SmokeDominique Medaglio, Warren B Bilker, Xiaoyan Han, et al.
Plos One|July 9, 2011
Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infectionCynthia Firnhaber, Livio Azzoni, Andrea S Foulkes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2010
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trialCharles Flexner, Camlin Tierney, Robert Gross, et al.
The Lancet. HIV|March 19, 2019
Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trialEvgeny Krupitsky, Elena Blokhina, Edwin Zvartau, et al.
Neurosurgery|March 15, 2018
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive SummaryAnand Rughani, Jason M Schwalb, Christos Sidiropoulos, et al.
Pharmacoepidemiology and Drug Safety|July 20, 2017
Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfectionVincent Lo Re, Bret Zeldow, Michael J Kallan, et al.
Pageof 25

Showing results (181-190 of 244) with videos related to

Sort By:
Pageof 25
Biological Psychiatry Global Open Science|December 24, 2025
A Placebo-Controlled Randomized Trial of the Effects of Escitalopram on Depressive Symptoms and Immune Function in People With HIVDwight L Evans, Sergei Spitsin, Kevin G Lynch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2018
Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and ResearchRobert A Schnoll, Morgan Thompson, Katrina Serrano, et al.
Methods of Information in Medicine|March 28, 2018
Development and Usability of a Smartphone Application for Tracking Antiretroviral Medication Refill Data for Human Immunodeficiency VirusDagan Coppock, Dikai Zambo, Dumisani Moyo, et al.
AIDS (London, England)|April 5, 2019
Differences in the rate of nicotine metabolism among smokers with and without HIVRebecca L Ashare, Morgan Thompson, Frank Leone, et al.
Clinical Pharmacology and Therapeutics|October 3, 2023
Nicotine Metabolite Ratio Decreases After Switching Off Efavirenz-Based Therapy in People With HIV Who SmokeDominique Medaglio, Warren B Bilker, Xiaoyan Han, et al.
Plos One|July 9, 2011
Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infectionCynthia Firnhaber, Livio Azzoni, Andrea S Foulkes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2010
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trialCharles Flexner, Camlin Tierney, Robert Gross, et al.
The Lancet. HIV|March 19, 2019
Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trialEvgeny Krupitsky, Elena Blokhina, Edwin Zvartau, et al.
Neurosurgery|March 15, 2018
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive SummaryAnand Rughani, Jason M Schwalb, Christos Sidiropoulos, et al.
Pharmacoepidemiology and Drug Safety|July 20, 2017
Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfectionVincent Lo Re, Bret Zeldow, Michael J Kallan, et al.
Pageof 25